PAVmed
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 107
- Market Cap
- -
- Introduction
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. The company's products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. PAVmed was founded on June 26, 2014 and is headquartered in New York, NY.
PR-0164 First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System
Not Applicable
Active, not recruiting
- Conditions
- Chronic Kidney Disease stage4Chronic Kidney Disease stage3Poor Vascular AccessChronic Kidney Disease Stage 5
- Interventions
- Device: PAVmed PortIOâ„¢ Intraosseous Infusion System
- First Posted Date
- 2023-09-14
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- PAVmed Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06037265
- Locations
- 🇨🇴
Cediul, Barranquilla, Atlantico, Colombia
🇨🇴Centro Medico Imbanaco, Cali, Valle De Cauca, Colombia
🇨🇴Sabbag Radiologos, Barranquilla, Atlantico, Colombia
PAVmed CarpX Device Clinical Study
Not Applicable
Completed
- Conditions
- Carpal Tunnel Syndrome
- Interventions
- Device: CarpX Device
- First Posted Date
- 2018-11-20
- Last Posted Date
- 2020-05-01
- Lead Sponsor
- PAVmed Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT03747510
- Locations
- 🇳🇿
Christchurch Hospital, Christchurch, New Zealand
© Copyright 2025. All Rights Reserved by MedPath